Plasma lipid measurement
Related entities
Findings (27)
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%
None
improvementFenofibrate added to simvastatin increased HDL-C by 6.3% (from 0.98 to 1.05 mmol/l) and decreased triglycerides by 21.2% (from 1.85 to 1.37 mmol/l) at 1 year, with no difference in LDL-C between group
Effect: improvement; HDL-C +6.3%, triglycerides -21.2%